ONTRUZANT

ONTRUZANT was reported 522 times

ONTRUZANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC STENOSIS 8 0.0437
1 FOLLICULAR DISORDER 1 0.0278
2 GASTROINTESTINAL ANASTOMOTIC LEAK 8 0.0205
3 GASTROINTESTINAL STENOSIS 8 0.0176
4 MUCOSAL NECROSIS 2 0.0127
5 EYE INFARCTION 1 0.0100
6 LYMPHATIC FISTULA 1 0.0100
7 NONINFECTIVE CONJUNCTIVITIS 1 0.0100
8 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 7 0.0083
9 URINARY TRACT INFECTION ENTEROCOCCAL 7 0.0075
10 ANASTOMOTIC LEAK 5 0.0072
11 TRACHEAL INJURY 1 0.0068
12 PRERENAL FAILURE 8 0.0057
13 MACROGLOSSIA 3 0.0055
14 IMMUNE-MEDIATED ADVERSE REACTION 8 0.0052
15 EXPOSURE TO SARS-COV-2 8 0.0047
16 MUCOSAL DRYNESS 9 0.0045
17 THROMBOCYTOPENIC PURPURA 6 0.0044
18 PERICARDIAL DRAINAGE 1 0.0042
19 XEROPHTHALMIA 2 0.0034
20 TUMOUR PAIN 4 0.0030
21 VASCULAR INSUFFICIENCY 1 0.0026
22 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
23 LYMPH GLAND INFECTION 1 0.0022
24 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
25 ABDOMINAL INFECTION 5 0.0020
26 OEDEMA MUCOSAL 2 0.0019
27 IMMEDIATE POST-INJECTION REACTION 2 0.0018
28 CATHETER SITE INFLAMMATION 1 0.0018
29 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
30 EMBOLISM ARTERIAL 2 0.0017
31 GASTROINTESTINAL OBSTRUCTION 4 0.0017
32 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
33 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
34 POSTOPERATIVE ADHESION 1 0.0015
35 POLYNEUROPATHY 18 0.0015
36 MYOPERICARDITIS 1 0.0013
37 ONYCHOLYSIS 2 0.0013
38 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
39 BREAST OPERATION 1 0.0012
40 INFLAMMATORY MARKER INCREASED 6 0.0012
41 TONGUE PRURITUS 1 0.0012
42 MASTECTOMY 2 0.0011
43 HILAR LYMPHADENOPATHY 1 0.0011
44 OROPHARYNGEAL CANDIDIASIS 1 0.0011
45 CARDIAC DYSFUNCTION 4 0.0011
46 DYSPNOEA AT REST 3 0.0010
47 HYPOMAGNESAEMIA 14 0.0010
48 POST PROCEDURAL INFECTION 8 0.0010
49 CAPILLARY LEAK SYNDROME 2 0.0010
50 EJECTION FRACTION DECREASED 15 0.0010
51 LIVEDO RETICULARIS 2 0.0010
52 HYPOKALAEMIA 44 0.0010
53 PARONYCHIA 4 0.0009
54 RADIATION SKIN INJURY 1 0.0009
55 HYPERTRANSAMINASAEMIA 6 0.0009
56 TYPE I HYPERSENSITIVITY 3 0.0009
57 SENSE OF OPPRESSION 1 0.0008
58 EYE OEDEMA 2 0.0008
59 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
60 AZOTAEMIA 3 0.0008
61 LYMPHOEDEMA 5 0.0007
62 ANAL HAEMORRHAGE 2 0.0007
63 DUODENAL ULCER 5 0.0007
64 GASTROINTESTINAL NECROSIS 2 0.0007
65 MOUTH HAEMORRHAGE 5 0.0007
66 VARICES OESOPHAGEAL 2 0.0007
67 INFECTIOUS PLEURAL EFFUSION 1 0.0007
68 FLANK PAIN 6 0.0006
69 INHIBITORY DRUG INTERACTION 1 0.0006
70 PHARYNGEAL PARAESTHESIA 1 0.0006
71 SHOCK HAEMORRHAGIC 5 0.0006
72 DEVICE RELATED INFECTION 9 0.0006
73 RENAL PAIN 6 0.0006
74 ILEUS 7 0.0006
75 DIVERTICULUM 4 0.0006
76 CEREBRAL VENOUS THROMBOSIS 1 0.0006
77 C-REACTIVE PROTEIN INCREASED 20 0.0005
78 HYPERTENSIVE CRISIS 6 0.0005
79 HEPATIC ENCEPHALOPATHY 5 0.0005
80 CONCUSSION 4 0.0005
81 STRESS CARDIOMYOPATHY 3 0.0005
82 HYPOVOLAEMIA 3 0.0005
83 CHOLECYSTITIS 6 0.0005
84 HYPERURICAEMIA 2 0.0005
85 CONJUNCTIVITIS 9 0.0005
86 HYPERPYREXIA 2 0.0005
87 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
88 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
89 LEUKOCYTOSIS 8 0.0004
90 GASTRIC HAEMORRHAGE 5 0.0004
91 ELECTROLYTE IMBALANCE 5 0.0004
92 EXTRASYSTOLES 3 0.0004
93 HEPATOTOXICITY 9 0.0004
94 CHILLS 47 0.0004
95 HYDRONEPHROSIS 3 0.0004
96 ERYSIPELAS 2 0.0004
97 TROPONIN INCREASED 3 0.0004
98 CARDIOVASCULAR DISORDER 10 0.0004
99 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
100 HYPERTHERMIA 3 0.0004
101 CATHETER SITE PAIN 1 0.0004
102 TONSILLITIS 2 0.0004
103 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
104 SKIN LACERATION 4 0.0004
105 IMPAIRED GASTRIC EMPTYING 5 0.0004
106 STAPHYLOCOCCAL INFECTION 12 0.0004
107 PRODUCT USE IN UNAPPROVED INDICATION 89 0.0004
108 INTESTINAL PERFORATION 4 0.0004
109 MOUTH SWELLING 2 0.0003
110 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
111 ANAEMIA 61 0.0003
112 INFUSION RELATED REACTION 21 0.0003
113 ABDOMINAL ADHESIONS 1 0.0003
114 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
115 PROCTALGIA 2 0.0003
116 FEBRILE NEUTROPENIA 20 0.0003
117 HYPOTONIA 3 0.0003
118 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
119 FACE OEDEMA 5 0.0003
120 CIRCULATORY COLLAPSE 5 0.0003
121 HYPERBILIRUBINAEMIA 3 0.0003
122 VENTRICULAR EXTRASYSTOLES 3 0.0003
123 OSTEONECROSIS OF JAW 7 0.0003
124 BREAST PAIN 3 0.0003
125 BREAST CANCER METASTATIC 3 0.0003
126 GASTROENTERITIS 4 0.0003
127 RESPIRATORY TRACT INFECTION 7 0.0003
128 POLYDIPSIA 1 0.0003
129 VERTIGO 15 0.0002
130 ANAPHYLACTOID REACTION 1 0.0002
131 DIARRHOEA 152 0.0002
132 HEPATIC FAILURE 7 0.0002
133 MUCOSAL INFLAMMATION 6 0.0002
134 TUMOUR LYSIS SYNDROME 2 0.0002
135 RESPIRATORY RATE INCREASED 2 0.0002
136 IRON DEFICIENCY 1 0.0002
137 THROAT TIGHTNESS 6 0.0002
138 DYSPHAGIA 21 0.0002
139 VASCULAR DEVICE INFECTION 1 0.0002
140 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
141 RESPIRATORY DISTRESS 6 0.0002
142 LOCALISED OEDEMA 1 0.0002
143 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
144 FEELING COLD 6 0.0002
145 SKIN REACTION 3 0.0002
146 PAIN IN JAW 6 0.0002
147 BRONCHOSPASM 3 0.0002
148 ENCEPHALOPATHY 5 0.0002
149 ACUTE KIDNEY INJURY 31 0.0002
150 PYREXIA 67 0.0002
151 CYANOSIS 3 0.0002
152 SEPSIS 21 0.0002
153 SURGERY 11 0.0002
154 DYSPNOEA EXERTIONAL 7 0.0002
155 NEUTROPENIA 25 0.0002
156 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
157 PROCEDURAL PAIN 5 0.0002
158 HEART RATE ABNORMAL 1 0.0002
159 ACUTE MYOCARDIAL INFARCTION 5 0.0002
160 SINUS HEADACHE 1 0.0002
161 STOMATITIS 10 0.0002
162 INFUSION SITE EXTRAVASATION 1 0.0002
163 INCOHERENT 1 0.0002
164 EAR PAIN 3 0.0002
165 TERMINAL STATE 1 0.0001
166 TASTE DISORDER 3 0.0001
167 FEELING HOT 9 0.0001
168 ABNORMAL LOSS OF WEIGHT 1 0.0001
169 RESPIRATION ABNORMAL 1 0.0001
170 WOUND 4 0.0001
171 THROMBOCYTOPENIA 16 0.0001
172 OXYGEN SATURATION DECREASED 8 0.0001
173 TONGUE DISORDER 1 0.0001
174 INFECTION 20 0.0001
175 MELAENA 3 0.0001
176 TACHYCARDIA 12 0.0001
177 HEPATIC FUNCTION ABNORMAL 5 0.0001
178 EPISTAXIS 10 0.0001
179 COLITIS 5 0.0001
180 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
181 PLEURAL EFFUSION 8 0.0001
182 GASTROINTESTINAL INFLAMMATION 1 0.0001
183 RHINITIS 1 0.0001
184 CEREBRAL INFARCTION 3 0.0001
185 INFLAMMATION 6 0.0001
186 CARDIAC FAILURE 9 0.0001
187 CARDIOTOXICITY 1 0.0001
188 PULMONARY OEDEMA 5 0.0001
189 PAIN OF SKIN 3 0.0001
190 RESPIRATORY FAILURE 8 0.0001
191 FLUSHING 11 0.0001
192 ABDOMINAL PAIN 25 0.0001
193 OEDEMA PERIPHERAL 13 0.0001
194 DEHYDRATION 14 0.0001
195 VOMITING 49 0.0001
196 PRODUCT SUBSTITUTION ISSUE 6 0.0001
197 INTERSTITIAL LUNG DISEASE 5 0.0001
198 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
199 TREMOR 17 0.0001
200 BODY TEMPERATURE DECREASED 1 0.0001
201 PRESCRIBED UNDERDOSE 2 0.0001
202 LACRIMATION INCREASED 3 0.0001
203 TOXIC SKIN ERUPTION 1 0.0001
204 BODY TEMPERATURE INCREASED 2 0.0001
205 ERYTHEMA 20 0.0001
206 NEUROPATHY PERIPHERAL 9 0.0001
207 BLOOD CREATININE INCREASED 6 0.0001
208 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
209 ORAL PAIN 2 0.0001
210 HYPOXIA 3 0.0001
211 NAUSEA 66 0.0001
212 BLOOD PRESSURE FLUCTUATION 2 0.0001
213 PRESYNCOPE 2 0.0001
214 UNDERDOSE 6 0.0001
215 SMALL INTESTINAL OBSTRUCTION 1 0.0001
216 GENERALISED OEDEMA 1 0.0001
217 DYSGEUSIA 6 0.0001
218 PHARYNGITIS 1 0.0001
219 DERMATITIS ALLERGIC 1 0.0001
220 COUGH 22 0.0001
221 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
222 CHEST DISCOMFORT 8 0.0001
223 INFUSION SITE PAIN 1 0.0001
224 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
225 OFF LABEL USE 67 0.0001
226 HYPERTENSION 16 0.0001
227 ADVERSE REACTION 1 0.0001
228 TACHYPNOEA 1 0.0001
229 PNEUMONITIS 2 0.0001
230 DYSPNOEA 41 0.0001
231 NECK PAIN 4 0.0001
232 COVID-19 12 0.0001
233 BONE PAIN 4 0.0001
234 WEIGHT DECREASED 19 0.0001
235 URINARY INCONTINENCE 2 0.0001
236 HYPOAESTHESIA ORAL 1 0.0001
237 CORONARY ARTERY DISEASE 2 0.0001
238 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
239 EPILEPSY 2 0.0001
240 HYPERSENSITIVITY 12 0.0001
241 PULMONARY EMBOLISM 6 0.0001
242 PRODUCTIVE COUGH 3 0.0001
243 CONDITION AGGRAVATED 19 0.0001
244 ATRIAL FIBRILLATION 6 0.0001
245 SKIN DISORDER 2 0.0001
246 DRY SKIN 8 0.0001
247 BLOOD PRESSURE INCREASED 9 0.0001
248 SINUSITIS 6 0.0001
249 COLD SWEAT 1 0.0001
250 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
251 HEAD DISCOMFORT 1 0.0001
252 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
253 BACK PAIN 13 0.0001
254 GASTROINTESTINAL DISORDER 5 0.0001
255 CHEST PAIN 10 0.0001
256 URINARY TRACT INFECTION 9 0.0001
257 RENAL FAILURE 7 0.0001
258 SEIZURE 6 0.0001
259 THROMBOSIS 4 0.0000
260 HAEMOGLOBIN DECREASED 5 0.0000
261 PULMONARY HYPERTENSION 1 0.0000
262 PRODUCT USE ISSUE 9 0.0000
263 TOXICITY TO VARIOUS AGENTS 8 0.0000
264 RETCHING 1 0.0000
265 JOINT INJURY 1 0.0000
266 RECTAL HAEMORRHAGE 2 0.0000
267 RHINORRHOEA 3 0.0000
268 RASH MACULO-PAPULAR 1 0.0000
269 PARAESTHESIA 7 0.0000
270 PERICARDIAL EFFUSION 1 0.0000
271 DECREASED APPETITE 10 0.0000
272 DRUG INTOLERANCE 4 0.0000
273 DYSPEPSIA 4 0.0000
274 LEUKOPENIA 2 0.0000
275 HEADACHE 25 0.0000
276 HAEMATEMESIS 1 0.0000
277 HEPATITIS 1 0.0000
278 LOSS OF CONSCIOUSNESS 5 0.0000
279 SKIN ULCER 1 0.0000
280 BRADYCARDIA 2 0.0000
281 BREAST CANCER FEMALE 1 0.0000
282 MALAISE 16 0.0000
283 SKIN LESION 1 0.0000
284 ANAPHYLACTIC REACTION 2 0.0000
285 SKIN EXFOLIATION 3 0.0000
286 EYE PAIN 2 0.0000
287 MUSCULAR WEAKNESS 4 0.0000
288 SOMNOLENCE 7 0.0000
289 RASH 15 0.0000
290 DISEASE PROGRESSION 4 0.0000
291 WHEEZING 2 0.0000
292 ILL-DEFINED DISORDER 2 0.0000
293 LIMB DISCOMFORT 1 0.0000
294 FATIGUE 25 0.0000
295 CONSTIPATION 7 0.0000
296 PRURITUS 12 0.0000
297 HYPERHIDROSIS 4 0.0000
298 SWELLING FACE 2 0.0000
299 HYPOTENSION 6 0.0000
300 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
301 MYALGIA 5 0.0000
302 HAEMATURIA 1 0.0000
303 DEVICE USE ERROR 1 0.0000
304 NEOPLASM PROGRESSION 1 0.0000
305 OVERDOSE 6 0.0000
306 HYPERGLYCAEMIA 1 0.0000
307 PAIN 14 0.0000
308 THROAT IRRITATION 1 0.0000
309 ADVERSE DRUG REACTION 2 0.0000
310 MUSCLE SPASMS 4 0.0000
311 SKIN DISCOLOURATION 1 0.0000
312 OROPHARYNGEAL PAIN 2 0.0000
313 CARDIAC DISORDER 2 0.0000
314 ARRHYTHMIA 1 0.0000
315 SYNCOPE 2 0.0000
316 CELLULITIS 1 0.0000
317 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
318 THERAPY CESSATION 1 0.0000
319 ARTHRALGIA 8 0.0000
320 OEDEMA 1 0.0000
321 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
322 NEOPLASM MALIGNANT 1 0.0000
323 HEPATIC ENZYME INCREASED 1 0.0000
324 AGITATION 1 0.0000
325 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
326 FALL 4 0.0000
327 URTICARIA 2 0.0000
328 CEREBROVASCULAR ACCIDENT 2 0.0000
329 BALANCE DISORDER 1 0.0000
330 DEVICE ISSUE 1 0.0000
331 NASOPHARYNGITIS 2 0.0000
332 MIGRAINE 1 0.0000
333 PAIN IN EXTREMITY 3 0.0000
334 HEART RATE INCREASED 1 0.0000
335 DIZZINESS 5 0.0000
336 ABDOMINAL DISTENSION 1 0.0000
337 PNEUMONIA 3 0.0000
338 INFLUENZA 1 0.0000
339 ASTHENIA 3 0.0000
340 PRODUCT QUALITY ISSUE 1 0.0000
341 HYPOAESTHESIA 1 0.0000
342 PERIPHERAL SWELLING 1 0.0000
343 CONFUSIONAL STATE 1 0.0000
344 DEATH 5 0.0000
345 MYOCARDIAL INFARCTION 1 0.0000
346 BLOOD GLUCOSE INCREASED 1 0.0000
347 FEELING ABNORMAL 1 0.0000
348 DRUG INEFFECTIVE 5 0.0000
349 INSOMNIA 1 0.0000
350 INJECTION SITE PAIN 1 0.0000